CLOVER HEALTH INVESTMENTS, CORP. /DE - Common Stock (CLOV)

CUSIP: 18914F103

Q3 2024 13F Holders as of 30 Sep 2024

Type / Class
Equity / Common Stock
Shares outstanding
416,598,522
Total 13F shares
82,031,282
Share change
+8,480,035
Total reported value
$231,318,941
Put/Call ratio
50%
Price per share
$2.82
Number of holders
154
Value change
+$27,492,527
Number of buys
86
Number of sells
54

Sponsored

Quarterly Holders Quick Answers

What is CUSIP 18914F103?
CUSIP 18914F103 identifies CLOV - CLOVER HEALTH INVESTMENTS, CORP. /DE - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of CLOV - CLOVER HEALTH INVESTMENTS, CORP. /DE - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
Chamath Palihapitiya
3/4/5
FORMER CHIEF EXECUTIVE OFFICER AND DIRECTOR, 10%+ Owner
class O/S missing
30,147,610
$29,544,657 07 Jul 2021
GREENOAKS CAPITAL PARTNERS LLC
3/4/5
Other*, 10%+ Owner
class O/S missing
25,754,556
$24,466,828 22 Nov 2021
VANGUARD GROUP INC
13F
Company
4.2%
17,345,012
$21,334,365 30 Jun 2024
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
2.7%
11,272,300
$13,864,929 30 Jun 2024
13F
BlackRock Finance, Inc.
13F
Company
2.3%
9,539,168
$11,733,178 30 Jun 2024
13F
PNC FINANCIAL SERVICES GROUP, INC.
13F
Company
1.2%
5,010,666
$6,163,119 30 Jun 2024
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.95%
3,960,200
$4,873,321 30 Jun 2024
13F
Scott J. Leffler
3/4/5
Chief Financial Officer
class O/S missing
4,857,303
$4,760,157 25 Jan 2024
Aric R. Sharp
3/4/5
CEO of Value Based Care
class O/S missing
2,100,665
$3,907,237 09 Aug 2024
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.68%
2,849,955
$3,505,445 30 Jun 2024
13F
CLOVER HEALTH INVESTMENTS, CORP. /DE
3/4/5
Chief Technology Officer
class O/S missing
3,093,225
$3,031,361 31 Oct 2023
SUSQUEHANNA INTERNATIONAL GROUP, LLP
13F
Company
0.58%
2,408,978
$2,963,043 30 Jun 2024
13F
Joseph R. Martin
3/4/5
General Counsel
class O/S missing
2,718,857
$2,664,480 14 Jun 2023
Qube Research & Technologies Ltd
13F
Company
0.49%
2,020,809
$2,485,595 30 Jun 2024
13F
CITADEL ADVISORS LLC
13F
Company
0.4%
1,653,804
$2,034,179 30 Jun 2024
13F
TWO SIGMA INVESTMENTS, LP
13F
Company
0.34%
1,402,348
$1,724,888 30 Jun 2024
13F
Invesco Ltd.
13F
Company
0.32%
1,334,337
$1,641,235 30 Jun 2024
13F
STATE STREET CORP
13F
Company
0.32%
1,326,759
$1,631,914 30 Jun 2024
13F
GMT CAPITAL CORP
13F
Company
0.31%
1,305,200
$1,605,396 30 Jun 2024
13F
JANE STREET GROUP, LLC
13F
Company
0.29%
1,200,333
$1,476,410 30 Jun 2024
13F
MORGAN STANLEY
13F
Company
0.29%
1,188,122
$1,461,390 30 Jun 2024
13F
Nathaniel S. Turner
3/4/5
Director
class O/S missing
1,324,728
$1,258,492 07 Jan 2021
GSA CAPITAL PARTNERS LLP
13F
Company
0.22%
913,066
$1,123,000 30 Jun 2024
13F
XTX Topco Ltd
13F
Company
0.18%
757,689
$931,957 30 Jun 2024
13F
AQR CAPITAL MANAGEMENT LLC
13F
Company
0.18%
729,706
$897,538 30 Jun 2024
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.17%
716,329
$881,085 30 Jun 2024
13F
NORTHERN TRUST CORP
13F
Company
0.17%
695,595
$855,582 30 Jun 2024
13F
Prabhdeep Singh
3/4/5
Chief Growth Officer
class O/S missing
872,821
$855,365 16 Sep 2022
Connor, Clark & Lunn Investment Management Ltd.
13F
Company
0.15%
642,184
$789,886 30 Jun 2024
13F
Quadrature Capital Ltd
13F
Company
0.08%
350,301
$434,373 30 Jun 2024
13F
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main
13F
Company
0.07%
296,244
$364,380 30 Jun 2024
13F
CHOREO, LLC
13F
Company
0.07%
286,802
$344,162 30 Jun 2024
13F
SAGE RHINO CAPITAL LLC
13F
Company
0.06%
261,500
$321,645 30 Jun 2024
13F
State of Wyoming
13F
Company
0.05%
219,722
$270,258 30 Jun 2024
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.05%
204,770
$251,867 30 Jun 2024
13F
FreeGulliver LLC
13F
Company
0.04%
180,000
$221,400 30 Jun 2024
13F
COMMONWEALTH EQUITY SERVICES, LLC
13F
Company
0.04%
176,529
$217,000 30 Jun 2024
13F
TRUIST FINANCIAL CORP
13F
Company
0.04%
171,395
$210,816 30 Jun 2024
13F
Turtle Creek Wealth Advisors, LLC
13F
Company
0.04%
170,000
$209,100 30 Jun 2024
13F
CANADA PENSION PLAN INVESTMENT BOARD
13F
Company
0.04%
165,000
$202,950 30 Jun 2024
13F
Headlands Technologies LLC
13F
Company
0.04%
162,057
$199,330 30 Jun 2024
13F
CREDIT AGRICOLE S A
13F
Individual
0.04%
146,000
$179,580 30 Jun 2024
13F
SignalPoint Asset Management, LLC
13F
Company
0.03%
139,366
$171,420 30 Jun 2024
13F
Squarepoint Ops LLC
13F
Company
0.03%
130,352
$160,333 30 Jun 2024
13F
GROUP ONE TRADING LLC
13F
Company
0.03%
104,738
$128,828 30 Jun 2024
13F
Performa Ltd (US), LLC
13F
Company
0.02%
100,000
$123,000 30 Jun 2024
13F
WEALTH ENHANCEMENT ADVISORY SERVICES, LLC
13F
Company
0.02%
98,112
$120,678 30 Jun 2024
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
0.02%
94,128
$115,777 30 Jun 2024
13F
OSAIC HOLDINGS, INC.
13F
Company
0.02%
86,258
$106,032 30 Jun 2024
13F
ExodusPoint Capital Management, LP
13F
Company
0.02%
86,143
$106,000 30 Jun 2024
13F

Institutional Holders of CLOVER HEALTH INVESTMENTS, CORP. /DE - Common Stock (CLOV) as of Q3 2024

As of 30 Sep 2024, CLOVER HEALTH INVESTMENTS, CORP. /DE - Common Stock (CLOV) was held by 154 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 82,031,282 shares. The largest 10 holders included VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, BlackRock, Inc., GEODE CAPITAL MANAGEMENT, LLC, PNC Financial Services Group, Inc., CHARLES SCHWAB INVESTMENT MANAGEMENT INC, Qube Research & Technologies Ltd, STATE STREET CORP, SUSQUEHANNA INTERNATIONAL GROUP, LLP, and TWO SIGMA INVESTMENTS, LP. This page lists 155 institutional shareholders reporting positions in this security for the Q3 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q3 2024 vs Q2 2024 Across Filers

Q2 2024 holders
121
Q3 2024 holders
154
Holder diff
33
Investor Q2 2024 Shares Q3 2024 Shares Share Diff Share Chg % Q2 2024 Value $ Q3 2024 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.